Table 1. Relation between protein levels of ALK5-FL, ALK5-ICD, pSmad2/3, and PAI-1 and clinicopathological parameters.
ALK5-FL | ALK5-ICD | pSmad2/3 | PAI-1 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Parameter | na | Mean Rank | Pb | na | Mean Rank | Pb | na | Mean Rank | Pb | na | Mean Rank | Pb |
Grade | ||||||||||||
I | 76 | 74.1 | 76 | 70.34 | 76 | 69.9 | 76 | 64.41 | ||||
0.35 | 0.049 | 0.036 | <0.0001 | |||||||||
II | 78 | 80.81 | 78 | 84.48 | 78 | 84.9 | 78 | 90.26 | ||||
TNM Stage | ||||||||||||
Early Stage | ||||||||||||
(I+II) | 84 | 69.4 | 84 | 66.34 | 84 | 68.17 | 84 | 63.17 | ||||
0.014 | 0.001 | 0.004 | <0.0001 | |||||||||
Advanced Stage | ||||||||||||
(III+IV) | 70 | 87.22 | 70 | 90.89 | 70 | 88.7 | 70 | 94.7 | ||||
Metastasis | ||||||||||||
M0 | 114 | 74 | 114 | 71.25 | 114 | 70.1 | 114 | 70.1 | ||||
0.1 | 0.003 | <0.0001 | 0.001 | |||||||||
M1 | 40 | 87.49 | 40 | 95.31 | 40 | 98.59 | 40 | 98.59 | ||||
Tumor Size (mm) | ||||||||||||
<70 | 77 | 69.42 | 77 | 71.22 | 77 | 68.92 | 77 | 67.73 | ||||
0.024 | 0.08 | 0.017 | 0.007 | |||||||||
>70 | 77 | 85.58 | 77 | 83.78 | 77 | 86.08 | 77 | 87.27 | ||||
Number of patients
Groups were compared using Mann-Whitney U-test (Significant at P < 0.05)